The small GTPase RAB18: Insights into cellular steatosis, lipophagy and the non-alcoholic fatty liver disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Dortmund, Technische Universität, Dissertation, 2021

Keyword: Guanosine triphosphatase
Fatty liver
Fatty degeneration
Fettleber
Biomarker

Event: Veröffentlichung

(where): Dortmund

(who): Universitätsbibliothek Dortmund

(when): 2021

Creator: Rieck, Adrian

Contributor: Hengstler, Jan
Bastiaens, Philippe

Handle: 2003/40554

URN: urn:nbn:de:101:1-2021111202423443152417

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.02.0010, 12:27 AM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rieck, Adrian
Hengstler, Jan
Bastiaens, Philippe
Universitätsbibliothek Dortmund

Time of origin

2021

Other Objects (12)

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Hochschulschrift

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Hochschulschrift

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Hochschulschrift

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The small GTPase RAB18: Insights into cellular steatosis, lipophagy and the non-alcoholic fatty liver disease

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease

Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence

Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model

TRIM59 promotes steatosis and ferroptosis in non-alcoholic fatty liver disease via enhancing GPX4 ubiquitination

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

Pharmacological Treatment for Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

Elevated endotoxin levels in non-alcoholic fatty liver disease

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease

Murine one-carbon metabolism in non-alcoholic fatty liver disease

Related objects

Reset password